ADC Manufacturing

The ADC manufacturing process plays a critical role in the development of antibody-drug conjugates (ADCs), which are designed to deliver potent cytotoxic drugs directly to cancer cells, minimizing damage to healthy tissues. This process involves several key stages, including the conjugation of cytotoxic drugs to monoclonal antibodies, quality control, and rigorous testing for purity and stability. During the ADC manufacturing process, the stability of the conjugate is carefully optimized to ensure that the drug remains intact during circulation and only releases its payload at the target site. Each step must be precisely controlled to ensure the final product's safety, efficacy, and regulatory compliance.